Concepts (249)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Speech Disorders | 6 | 2017 | 189 | 1.520 |
Why?
|
| Drug Resistance, Viral | 8 | 2018 | 820 | 1.280 |
Why?
|
| Speech Intelligibility | 3 | 2017 | 81 | 1.030 |
Why?
|
| Antiretroviral Therapy, Highly Active | 11 | 2018 | 1872 | 1.020 |
Why?
|
| Anti-HIV Agents | 17 | 2021 | 4255 | 1.020 |
Why?
|
| Interpersonal Relations | 5 | 2017 | 1425 | 0.860 |
Why?
|
| Language Disorders | 3 | 2013 | 141 | 0.860 |
Why?
|
| Language Development Disorders | 3 | 2022 | 196 | 0.810 |
Why?
|
| Research Design | 3 | 2024 | 5984 | 0.800 |
Why?
|
| Viral Load | 14 | 2023 | 3300 | 0.790 |
Why?
|
| Australia | 11 | 2023 | 1167 | 0.760 |
Why?
|
| Child Behavior | 2 | 2017 | 839 | 0.730 |
Why?
|
| Child Language | 3 | 2017 | 64 | 0.700 |
Why?
|
| HIV-1 | 10 | 2018 | 6939 | 0.650 |
Why?
|
| Sample Size | 4 | 2024 | 845 | 0.650 |
Why?
|
| HIV Infections | 21 | 2021 | 16715 | 0.590 |
Why?
|
| Speech-Language Pathology | 4 | 2022 | 26 | 0.580 |
Why?
|
| Social Adjustment | 2 | 2016 | 631 | 0.550 |
Why?
|
| Phonetics | 4 | 2022 | 206 | 0.510 |
Why?
|
| Personal Satisfaction | 2 | 2016 | 643 | 0.480 |
Why?
|
| Schools | 3 | 2017 | 1433 | 0.470 |
Why?
|
| Child of Impaired Parents | 1 | 2017 | 455 | 0.460 |
Why?
|
| Language Development | 1 | 2014 | 187 | 0.460 |
Why?
|
| Nursing | 1 | 2012 | 40 | 0.430 |
Why?
|
| Peer Group | 1 | 2016 | 635 | 0.400 |
Why?
|
| Anti-Retroviral Agents | 4 | 2021 | 1714 | 0.390 |
Why?
|
| Child Day Care Centers | 4 | 2023 | 123 | 0.380 |
Why?
|
| Disabled Children | 1 | 2013 | 247 | 0.380 |
Why?
|
| Gene Products, pol | 1 | 2010 | 47 | 0.380 |
Why?
|
| Frustration | 1 | 2010 | 22 | 0.380 |
Why?
|
| Self Concept | 1 | 2016 | 1025 | 0.370 |
Why?
|
| Communication Barriers | 2 | 2011 | 398 | 0.350 |
Why?
|
| RNA, Viral | 6 | 2016 | 2901 | 0.340 |
Why?
|
| Algorithms | 2 | 2019 | 13882 | 0.320 |
Why?
|
| Models, Statistical | 1 | 2023 | 5101 | 0.310 |
Why?
|
| Psychometrics | 1 | 2017 | 3003 | 0.310 |
Why?
|
| Parents | 7 | 2017 | 3405 | 0.300 |
Why?
|
| Genotype | 4 | 2018 | 12952 | 0.280 |
Why?
|
| Child, Preschool | 21 | 2023 | 41005 | 0.280 |
Why?
|
| Career Choice | 1 | 2012 | 744 | 0.280 |
Why?
|
| Speech Production Measurement | 3 | 2017 | 99 | 0.260 |
Why?
|
| Speech Perception | 1 | 2010 | 490 | 0.260 |
Why?
|
| Child Health Services | 1 | 2011 | 667 | 0.260 |
Why?
|
| Health Services Needs and Demand | 1 | 2013 | 1410 | 0.260 |
Why?
|
| Cluster Analysis | 3 | 2021 | 2715 | 0.240 |
Why?
|
| Medication Adherence | 3 | 2021 | 2063 | 0.230 |
Why?
|
| Speech Therapy | 3 | 2013 | 57 | 0.230 |
Why?
|
| Faculty | 5 | 2014 | 387 | 0.230 |
Why?
|
| Hepatitis B | 2 | 2019 | 695 | 0.220 |
Why?
|
| Art Therapy | 1 | 2022 | 9 | 0.210 |
Why?
|
| Language Therapy | 2 | 2013 | 25 | 0.210 |
Why?
|
| CD4 Lymphocyte Count | 6 | 2016 | 2560 | 0.210 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2013 | 3020 | 0.200 |
Why?
|
| Women, Working | 1 | 2002 | 87 | 0.200 |
Why?
|
| Infectious Disease Transmission, Vertical | 2 | 2019 | 1320 | 0.200 |
Why?
|
| Health Services Accessibility | 4 | 2016 | 5135 | 0.200 |
Why?
|
| Longitudinal Studies | 7 | 2017 | 13991 | 0.190 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2023 | 9955 | 0.190 |
Why?
|
| Attention | 2 | 2010 | 2397 | 0.190 |
Why?
|
| Thailand | 3 | 2019 | 296 | 0.180 |
Why?
|
| Object Attachment | 1 | 2002 | 313 | 0.170 |
Why?
|
| Reverse Transcriptase Inhibitors | 4 | 2017 | 615 | 0.160 |
Why?
|
| Mother-Child Relations | 1 | 2002 | 481 | 0.160 |
Why?
|
| Male | 37 | 2021 | 350115 | 0.160 |
Why?
|
| Humans | 50 | 2024 | 744366 | 0.160 |
Why?
|
| Hepatitis B virus | 2 | 2019 | 513 | 0.160 |
Why?
|
| Confidence Intervals | 1 | 2024 | 2971 | 0.160 |
Why?
|
| Parent-Child Relations | 2 | 2014 | 747 | 0.150 |
Why?
|
| Health Literacy | 1 | 2023 | 414 | 0.150 |
Why?
|
| Immune Reconstitution Inflammatory Syndrome | 1 | 2017 | 66 | 0.150 |
Why?
|
| Ritonavir | 3 | 2017 | 322 | 0.150 |
Why?
|
| Mental Disorders | 1 | 2017 | 6598 | 0.150 |
Why?
|
| Zidovudine | 1 | 2019 | 620 | 0.150 |
Why?
|
| Probability | 1 | 2023 | 2506 | 0.150 |
Why?
|
| Child | 13 | 2017 | 77709 | 0.150 |
Why?
|
| HIV | 2 | 2016 | 1604 | 0.140 |
Why?
|
| Female | 35 | 2021 | 380193 | 0.140 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2011 | 3922 | 0.140 |
Why?
|
| Vietnam | 1 | 2017 | 408 | 0.140 |
Why?
|
| Antiviral Agents | 2 | 2019 | 2987 | 0.140 |
Why?
|
| Multidrug Resistance-Associated Proteins | 1 | 2015 | 107 | 0.130 |
Why?
|
| Viremia | 1 | 2016 | 736 | 0.110 |
Why?
|
| Receptors, CCR5 | 1 | 2015 | 498 | 0.110 |
Why?
|
| Renal Insufficiency | 1 | 2019 | 804 | 0.110 |
Why?
|
| Data Interpretation, Statistical | 1 | 2023 | 2716 | 0.110 |
Why?
|
| HIV Reverse Transcriptase | 1 | 2013 | 213 | 0.110 |
Why?
|
| Family | 3 | 2010 | 3147 | 0.110 |
Why?
|
| Paraparesis, Tropical Spastic | 1 | 2012 | 32 | 0.110 |
Why?
|
| Europe | 3 | 2017 | 3338 | 0.110 |
Why?
|
| Students, Nursing | 1 | 2012 | 45 | 0.110 |
Why?
|
| Translocation, Genetic | 1 | 2017 | 1420 | 0.100 |
Why?
|
| Quality of Life | 4 | 2021 | 12802 | 0.100 |
Why?
|
| Plasma | 1 | 2015 | 575 | 0.100 |
Why?
|
| Glomerular Filtration Rate | 2 | 2019 | 2166 | 0.100 |
Why?
|
| Salvage Therapy | 1 | 2018 | 1275 | 0.100 |
Why?
|
| Communication Disorders | 1 | 2011 | 51 | 0.100 |
Why?
|
| Survival Analysis | 1 | 2024 | 10252 | 0.090 |
Why?
|
| Professional-Family Relations | 1 | 2014 | 482 | 0.090 |
Why?
|
| Computer Simulation | 1 | 2024 | 6194 | 0.090 |
Why?
|
| Nonverbal Communication | 1 | 2010 | 63 | 0.090 |
Why?
|
| Information Seeking Behavior | 1 | 2011 | 113 | 0.090 |
Why?
|
| Adolescent | 11 | 2018 | 85779 | 0.090 |
Why?
|
| Financing, Government | 1 | 2013 | 468 | 0.090 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2019 | 2026 | 0.090 |
Why?
|
| Adenine | 1 | 2015 | 936 | 0.090 |
Why?
|
| Health Resources | 1 | 2016 | 911 | 0.090 |
Why?
|
| Cross-Sectional Studies | 2 | 2021 | 25039 | 0.090 |
Why?
|
| Cyclosporine | 1 | 2012 | 788 | 0.090 |
Why?
|
| Drug Monitoring | 2 | 2017 | 956 | 0.090 |
Why?
|
| Hearing Disorders | 1 | 2009 | 124 | 0.080 |
Why?
|
| Dysphonia | 1 | 2012 | 144 | 0.080 |
Why?
|
| Capacity Building | 1 | 2011 | 248 | 0.080 |
Why?
|
| Vocabulary | 1 | 2009 | 169 | 0.080 |
Why?
|
| Multilingualism | 1 | 2009 | 87 | 0.080 |
Why?
|
| Inservice Training | 1 | 2011 | 392 | 0.080 |
Why?
|
| Language Tests | 1 | 2009 | 202 | 0.080 |
Why?
|
| Infant | 8 | 2019 | 35134 | 0.080 |
Why?
|
| Quality Improvement | 1 | 2023 | 3749 | 0.080 |
Why?
|
| Students | 1 | 2017 | 1647 | 0.080 |
Why?
|
| Focus Groups | 1 | 2012 | 1321 | 0.080 |
Why?
|
| Adult | 19 | 2023 | 214052 | 0.080 |
Why?
|
| Interview, Psychological | 1 | 2010 | 812 | 0.070 |
Why?
|
| Antibodies, Neutralizing | 1 | 2016 | 1978 | 0.070 |
Why?
|
| Awareness | 1 | 2011 | 640 | 0.070 |
Why?
|
| Bone Density | 1 | 2019 | 3468 | 0.070 |
Why?
|
| Mutation, Missense | 2 | 2013 | 2566 | 0.070 |
Why?
|
| Time Factors | 6 | 2017 | 40075 | 0.070 |
Why?
|
| Personality | 1 | 2009 | 552 | 0.070 |
Why?
|
| Siblings | 1 | 2009 | 854 | 0.060 |
Why?
|
| Social Environment | 1 | 2010 | 1022 | 0.060 |
Why?
|
| Research | 1 | 2013 | 1999 | 0.060 |
Why?
|
| Follow-Up Studies | 3 | 2016 | 39052 | 0.060 |
Why?
|
| Drug Administration Schedule | 1 | 2013 | 4933 | 0.060 |
Why?
|
| Lymphocyte Activation | 1 | 2015 | 5524 | 0.060 |
Why?
|
| Disability Evaluation | 1 | 2012 | 1828 | 0.060 |
Why?
|
| Interviews as Topic | 1 | 2011 | 2539 | 0.060 |
Why?
|
| Data Collection | 1 | 2013 | 3339 | 0.060 |
Why?
|
| Qualitative Research | 1 | 2012 | 2682 | 0.060 |
Why?
|
| Health Care Surveys | 1 | 2011 | 2453 | 0.060 |
Why?
|
| Environment | 1 | 2009 | 1123 | 0.060 |
Why?
|
| Needs Assessment | 1 | 2009 | 1147 | 0.050 |
Why?
|
| Nurses | 1 | 2012 | 2462 | 0.050 |
Why?
|
| Polymorphism, Genetic | 1 | 2013 | 4328 | 0.050 |
Why?
|
| Cytokines | 1 | 2017 | 7323 | 0.050 |
Why?
|
| Child Care | 1 | 2003 | 119 | 0.050 |
Why?
|
| Stuttering | 1 | 2022 | 25 | 0.050 |
Why?
|
| Personality Development | 1 | 2002 | 245 | 0.050 |
Why?
|
| Kidney | 1 | 2017 | 7184 | 0.050 |
Why?
|
| Liver | 1 | 2017 | 7475 | 0.050 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2014 | 4386 | 0.050 |
Why?
|
| Activities of Daily Living | 1 | 2011 | 2419 | 0.050 |
Why?
|
| Reproducibility of Results | 2 | 2017 | 19905 | 0.050 |
Why?
|
| Caregivers | 1 | 2013 | 2095 | 0.050 |
Why?
|
| North America | 2 | 2017 | 1249 | 0.050 |
Why?
|
| Infant Care | 1 | 2002 | 183 | 0.050 |
Why?
|
| Patient Education as Topic | 1 | 2011 | 2278 | 0.050 |
Why?
|
| Health Policy | 1 | 2013 | 2661 | 0.050 |
Why?
|
| Molecular Sequence Data | 2 | 2012 | 18111 | 0.050 |
Why?
|
| Young Adult | 6 | 2019 | 56429 | 0.050 |
Why?
|
| Psychological Tests | 1 | 2002 | 651 | 0.050 |
Why?
|
| DNA, Viral | 2 | 2018 | 2227 | 0.050 |
Why?
|
| Maternal Behavior | 1 | 2002 | 311 | 0.040 |
Why?
|
| Age Factors | 1 | 2017 | 18373 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 1 | 2016 | 9274 | 0.040 |
Why?
|
| Health Promotion | 1 | 2011 | 2205 | 0.040 |
Why?
|
| Immunosuppressive Agents | 1 | 2012 | 4153 | 0.040 |
Why?
|
| Treatment Failure | 2 | 2016 | 2618 | 0.040 |
Why?
|
| Treatment Outcome | 8 | 2018 | 63107 | 0.040 |
Why?
|
| Freedom | 1 | 2017 | 69 | 0.040 |
Why?
|
| Hepatitis B e Antigens | 1 | 2018 | 133 | 0.040 |
Why?
|
| Comprehension | 1 | 2023 | 610 | 0.040 |
Why?
|
| Health Behavior | 1 | 2009 | 2635 | 0.040 |
Why?
|
| Auditory Perception | 1 | 2022 | 569 | 0.040 |
Why?
|
| Attitude | 1 | 2002 | 776 | 0.040 |
Why?
|
| Speech | 1 | 2022 | 541 | 0.040 |
Why?
|
| Hepatitis B Vaccines | 1 | 2018 | 194 | 0.040 |
Why?
|
| Alkynes | 1 | 2017 | 306 | 0.040 |
Why?
|
| Cystatin C | 1 | 2017 | 250 | 0.030 |
Why?
|
| Cyclopropanes | 1 | 2017 | 416 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2002 | 3508 | 0.030 |
Why?
|
| Benzoxazines | 1 | 2017 | 301 | 0.030 |
Why?
|
| Employment | 1 | 2002 | 1132 | 0.030 |
Why?
|
| DNA, Circular | 1 | 2015 | 97 | 0.030 |
Why?
|
| Sex Factors | 1 | 2009 | 10400 | 0.030 |
Why?
|
| Prevalence | 2 | 2010 | 15221 | 0.030 |
Why?
|
| Mutation | 2 | 2010 | 29786 | 0.030 |
Why?
|
| Alanine Transaminase | 1 | 2018 | 592 | 0.030 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2017 | 426 | 0.030 |
Why?
|
| Malawi | 1 | 2016 | 282 | 0.030 |
Why?
|
| Human Rights | 1 | 2017 | 307 | 0.030 |
Why?
|
| Double-Blind Method | 2 | 2019 | 12025 | 0.030 |
Why?
|
| Nevirapine | 1 | 2015 | 267 | 0.030 |
Why?
|
| Pregnancy | 3 | 2019 | 29144 | 0.030 |
Why?
|
| Medically Underserved Area | 1 | 2016 | 253 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2002 | 6366 | 0.030 |
Why?
|
| Social Class | 1 | 2002 | 1997 | 0.030 |
Why?
|
| Africa South of the Sahara | 1 | 2016 | 724 | 0.030 |
Why?
|
| Peru | 1 | 2016 | 881 | 0.030 |
Why?
|
| RNA | 1 | 2023 | 2749 | 0.030 |
Why?
|
| Postpartum Period | 1 | 2019 | 1086 | 0.030 |
Why?
|
| Standard of Care | 1 | 2016 | 564 | 0.030 |
Why?
|
| Victoria | 1 | 2011 | 67 | 0.030 |
Why?
|
| Creatinine | 1 | 2017 | 1919 | 0.030 |
Why?
|
| Brazil | 1 | 2016 | 1270 | 0.030 |
Why?
|
| Infant, Newborn | 3 | 2018 | 25628 | 0.030 |
Why?
|
| Middle Aged | 8 | 2019 | 213390 | 0.020 |
Why?
|
| Cohort Studies | 4 | 2017 | 40559 | 0.020 |
Why?
|
| South America | 1 | 2011 | 181 | 0.020 |
Why?
|
| Internet | 1 | 2023 | 3056 | 0.020 |
Why?
|
| Gestational Age | 1 | 2019 | 3493 | 0.020 |
Why?
|
| Poverty Areas | 1 | 2011 | 275 | 0.020 |
Why?
|
| South Africa | 1 | 2015 | 1731 | 0.020 |
Why?
|
| HIV Antibodies | 1 | 2016 | 1322 | 0.020 |
Why?
|
| Self Report | 1 | 2021 | 3553 | 0.020 |
Why?
|
| India | 1 | 2016 | 2197 | 0.020 |
Why?
|
| HIV Protease Inhibitors | 1 | 2012 | 430 | 0.020 |
Why?
|
| Phylogeny | 1 | 2016 | 2804 | 0.020 |
Why?
|
| Verbal Behavior | 1 | 2010 | 339 | 0.020 |
Why?
|
| Life Expectancy | 1 | 2015 | 1184 | 0.020 |
Why?
|
| Body Weight | 1 | 2019 | 4671 | 0.020 |
Why?
|
| Cholesterol | 1 | 2017 | 2919 | 0.020 |
Why?
|
| Writing | 1 | 2010 | 206 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2017 | 3203 | 0.020 |
Why?
|
| Factor Analysis, Statistical | 1 | 2010 | 977 | 0.020 |
Why?
|
| Child Welfare | 1 | 2011 | 523 | 0.020 |
Why?
|
| Risk Factors | 2 | 2016 | 72296 | 0.020 |
Why?
|
| Communication | 2 | 2012 | 3750 | 0.020 |
Why?
|
| Selection, Genetic | 1 | 2012 | 914 | 0.020 |
Why?
|
| Reading | 1 | 2010 | 558 | 0.020 |
Why?
|
| Aged | 5 | 2018 | 163288 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2017 | 3778 | 0.020 |
Why?
|
| United States | 1 | 2013 | 69872 | 0.020 |
Why?
|
| Perception | 1 | 2010 | 1198 | 0.010 |
Why?
|
| Residence Characteristics | 1 | 2013 | 2050 | 0.010 |
Why?
|
| Educational Status | 1 | 2011 | 2540 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2015 | 5388 | 0.010 |
Why?
|
| Health Care Costs | 1 | 2015 | 3208 | 0.010 |
Why?
|
| Cost of Illness | 1 | 2011 | 1860 | 0.010 |
Why?
|
| Learning | 1 | 2010 | 1711 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2012 | 4805 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 57776 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2015 | 7914 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2012 | 8319 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2015 | 10183 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2015 | 21748 | 0.010 |
Why?
|
| Inflammation | 1 | 2017 | 10637 | 0.010 |
Why?
|
| Program Evaluation | 1 | 2003 | 2488 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 17446 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2015 | 77460 | 0.000 |
Why?
|
Concepts
(249)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(16)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_